Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid‐induced rat autism model. Issue 49 (27th November 2015)
- Record Type:
- Journal Article
- Title:
- Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid‐induced rat autism model. Issue 49 (27th November 2015)
- Main Title:
- Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid‐induced rat autism model
- Authors:
- Gao, Jingquan
Wang, Xuelai
Sun, Hongli
Cao, Yonggang
Liang, Shuang
Wang, Han
Wang, Yanming
Yang, Feng
Zhang, Fengyu
Wu, Lijie - Abstract:
- Abstract: Prenatal exposure to valproic acid (VPA) in rat offspring is capable of inducing experimental autism with neurobehavioral aberrations. This study investigated the effect of docosahexaenoic acid (DHA) on hippocampal cell death, learning and memory alteration in an experimental rat autism model. We found that DHA supplementation (75, 150 or 300 mg/kg/day, 21 days) rescued the VPA (600 mg/kg) induced DHA reduction in plasma and hippocampus in a dose‐dependent manner, increased the levels of hippocampal p‐CaMKII and p‐CREB without affecting total protein level, and altered BDNF‐AKT‐Bcl‐2 signaling pathway, as well as inhibited the activity of caspase‐3. DHA also influenced the content of malondialdehyde (MDA) and the activities of antioxidant enzymes in the VPA‐treated offspring. Consistent with the previous results, we also observed that 300 mg/kg DHA supplementation markedly increased the cell survival, decreased the cell apoptosis, and increased mature neuronal cell in the hippocampus in VPA‐treated offspring. Utilizing the Morris water maze test, we found that DHA prevented cognitive impairment in offspring of VPA‐treated rats. The data suggested that DHA may play a neuroprotective role in hippocampal neuronal cell and ameliorates dysfunctions in learning and memory in this rat autism model. Thus, DHA could be used as treatment intervention for mitigating behavioral dysfunctions in autism spectrum disorder (ASD).
- Is Part Of:
- International journal of developmental neuroscience. Issue 49(2016:Apr.)
- Journal:
- International journal of developmental neuroscience
- Issue:
- Issue 49(2016:Apr.)
- Issue Display:
- Volume 49, Issue 49 (2016)
- Year:
- 2016
- Volume:
- 49
- Issue:
- 49
- Issue Sort Value:
- 2016-0049-0049-0000
- Page Start:
- 67
- Page End:
- 78
- Publication Date:
- 2015-11-27
- Subjects:
- Docosahexaenoic acid (DHA) -- Autism -- Neuroprotective -- Hippocampal cell -- Learning impairment -- Memory impairment
Developmental neurobiology -- Periodicals
Neurology -- Periodicals
Neurologie du développement -- Périodiques
Developmental neurobiology
Periodicals
612.8 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/1873474x ↗
http://www.sciencedirect.com/science/journal/07365748 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijdevneu.2015.11.006 ↗
- Languages:
- English
- ISSNs:
- 0736-5748
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.185100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13605.xml